- Use of ezetimibe results in more patients reaching lipid targets without side effects2014 | First Faculty of Medicine
- Combined therapy of mixed dyslipidemia in patients with high cardiovascular risk and changes in the lipid target values and atherogenic index of plasma2014 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Cardiovascular risk stratification and new serum lipid target levels2017 | First Faculty of Medicine
- Combined therapy of mixed dyslipidemia in patients with high cardiovascular risk and changes in the lipid target values and atherogenic index of plasma2014 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Basic changes in the guidelines for dyslipidemia management from the year 20192020 | Faculty of Medicine in Pilsen
- A practical approach to statin intolerance2015 | First Faculty of Medicine
- Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)2023 | First Faculty of Medicine
- Characteristics of patients with uncontrolled arterial hypertension and/or dyslipidemia in primary care in Czechia- LipitenCliDec Study: 1st phase results2020 | First Faculty of Medicine